METLIFE INC
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
MET$102.44+0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interim Condensed Consolidated Statements of Cash Flows
(In millions)
| Three MonthsEndedMarch 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Net cash provided by (used in) operating activities | $4,262 | $2,328 |
| Cash flows from investing activities | ||
| Sales, maturities and repayments of: | ||
| Fixed maturity securities available-for-sale | 14,062 | 11,469 |
| Equity securities | 9 | 37 |
| Mortgage loans | 3,234 | 2,217 |
| Real estate and real estate joint ventures | 48 | 143 |
| Other limited partnership interests | 301 | 402 |
| Short-term investments | 4,143 | 3,753 |
| Purchases and originations of: | ||
| Fixed maturity securities available-for-sale | (18,359) | (14,692) |
| Equity securities | (35) | (7) |
| Mortgage loans | (1,999) | (1,914) |
| Real estate and real estate joint ventures | (114) | (175) |
| Other limited partnership interests | (278) | (295) |
| Short-term investments | (4,443) | (2,642) |
| Cash received in connection with freestanding derivatives | 803 | 503 |
| Cash paid in connection with freestanding derivatives | (1,013) | (1,052) |
| Net change in policy loans | (87) | (80) |
| Net change in other invested assets | 457 | (280) |
| Other, net | (51) | (14) |
| Net cash provided by (used in) investing activities | (3,322) | (2,627) |
| Cash flows from financing activities | ||
| Policyholder account balances - deposits | 28,692 | 24,444 |
| Policyholder account balances - withdrawals | (26,916) | (23,373) |
| Net change in payables for collateral under securities loaned and other transactions | 233 | 50 |
| Long-term debt issued | 89 | 758 |
| Long-term debt repaid | (555) | (264) |
| Collateral financing arrangement repaid | (13) | (47) |
| Subordinated debt securities issued | 1,000 | — |
| Derivatives with certain financing elements and other derivative-related transactions, net | (71) | (55) |
| Proceeds from mortgage loan secured financing | 66 | 42 |
| Repayments of mortgage loan secured financing | (255) | (161) |
| Treasury stock acquired in connection with share repurchases | (1,411) | (1,172) |
| Dividends on preferred stock | (66) | (67) |
| Dividends on common stock | (374) | (377) |
| Other, net | (199) | (39) |
| Net cash provided by (used in) financing activities | 220 | (261) |
| Effect of change in foreign currency exchange rates on cash and cash equivalents balances | 98 | (239) |
| Change in cash and cash equivalents | 1,258 | (799) |
| Cash and cash equivalents, beginning of period | $20,068 | $20,639 |
| Cash and cash equivalents, end of period | $21,326 | $19,840 |
| Supplemental disclosures of cash flow information | ||
|---|---|---|
| Net cash paid (received) for: | ||
| Interest | $224 | $231 |
| Income tax | $147 | $130 |
| Non-cash transactions: | ||
| Other invested assets received in connection with the sale of other limited partnership interests | $20 | $349 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.